Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | PHYSITRACK PLC | Anne-Sophie D Andlau | Chairman of the Board of Directors | Acquisition | 4 000 | 14,141 | SEK | 56 564,8 | 2024-05-29 |
| 2024-05-31 | ATLAS COPCO AKTIEBOLAG | Eva Klasén | Other member of the company's administrative, management or supervisory body | Disposal | 100 000 | 170,085 | SEK | 17 008 510 | 2024-05-29 |
| 2024-05-31 | ATLAS COPCO AKTIEBOLAG | Marcus Hvied | Other member of the company's administrative, management or supervisory body | Acquisition | 1 500 | 198,8 | SEK | 298 200 | 2024-05-30 |
| 2024-05-31 | Swedish Orphan Biovitrum AB (publ) | Guido Oelkers | Chief Executive Officer (CEO)/Managing Directory | Disposal | 109 662 | 275,19 | SEK | 30 177 885,78 | 2024-05-28 |
| 2024-05-31 | Swedish Orphan Biovitrum AB (publ) | Guido Oelkers | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 110 000 | 204,25 | SEK | 22 467 500 | 2024-05-30 |
| 2024-05-31 | Swedish Orphan Biovitrum AB (publ) | Guido Oelkers | Chief Executive Officer (CEO)/Managing Directory | Disposal | 338 | 275,14 | SEK | 92 997,32 | 2024-05-28 |
| 2024-05-31 | Abliva AB | Eskil Elmér | Other member of the company's administrative, management or supervisory body | Allotment | 1 750 000 | 0,03 | SEK | 52 500 | 2024-05-29 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Hanna Olsson | Chief Financial Officer (CFO) | Exercise decrease | 39 375 | 0 | SEK | 0 | 2024-05-30 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Hanna Olsson | Chief Financial Officer (CFO) | Exercise increase | 39 375 | 0,2 | SEK | 7 875 | 2024-05-30 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Alan Raffensperger | Member of the Board of Directors | Exercise increase | 528 667 | 0,2 | SEK | 105 733,4 | 2024-05-29 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Alan Raffensperger | Member of the Board of Directors | Exercise decrease | 528 667 | 0 | SEK | 0 | 2024-05-29 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Mats Jörgen Zukunft Hansen | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 224 730 | 0,2 | SEK | 44 946 | 2024-05-29 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Mats Jörgen Zukunft Hansen | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 224 730 | 0,2 | SEK | 44 946 | 2024-05-29 |
| 2024-05-31 | Spago Nanomedical AB (publ) | Nicklas Westerholm | Member of the Board of Directors | Exercise increase | 64 167 | 0,2 | SEK | 12 833,4 | 2024-05-29 |
| 2024-05-31 | Transtema Group AB | Henning Sveder | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 12 000 | 12,46 | SEK | 149 520 | 2024-05-29 |
| 2024-05-31 | Transtema Group AB | Henning Sveder | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 3 900 | 12,58 | SEK | 49 062 | 2024-05-30 |
| 2024-05-31 | Ngenic AB | Björn Berg | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 5 000 | 2,576 | SEK | 12 881 | 2024-05-29 |
| 2024-05-31 | Medivir Aktiebolag | Pia Baumann | Other member of the company's administrative, management or supervisory body | Acquisition | 45 000 | 2,94 | SEK | 132 300 | 2024-05-28 |
| 2024-05-31 | Infrea AB | Carl Martin Reinholdsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 40 000 | 0,73 | SEK | 29 200 | 2024-05-29 |
| 2024-05-31 | Infrea AB | Olov Jonas Olsson | Other senior executive | Acquisition | 25 000 | 0,73 | SEK | 18 250 | 2024-05-29 |